The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. It has been examined that menstruation volume decreased or cycle lengthened in one-fifth of women who had COVID-19, and this condition was more intense in those who had severe COVID-19. Studies have shown that the possible effects of COVID-19 on the female genital system often remain theoretical hypotheses. In the literature, there was no study in which menstrual dysfunctions and secondary problems caused by the state of inactivity entering our lives during pandemic were discussed in a wide spectrum of women who had COVID-19. Therefore the aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Inclusion Criteria:

• Being between the ages of 18 and 45,
• PCR test result positive confirmed having COVID-19 infection,
• Women had at least one period of Menstrual cycle after COVID-19
• Being an Internet connection,
• To be able to speak and write in Turkish.

Exclusion Criteria:

• To be in the premenaposual/postmenopausal period (to be in the transition period to menopause or in the period after menopause.)
• Having insufficient co-operation.

female individuals aged 18-45 who have had COVID-19

The study will include 200 volunteers, female individuals aged 18-45 who have had COVID-19.